Parnell has appointed Sharon Holt as Vice President of US Pet Care, as the veterinary pharmaceutical company continues to expand its companion animal portfolio and strengthen its support for veterinary customers.
Holt brings more than 20 years of experience in the animal health industry. She joined Merial in 2002 and continued with the business following its acquisition by Boehringer Ingelheim in 2017. During her career, she has held leadership roles across sales, marketing, supply chain, commercial operations and business development.
In her new position, Holt will lead Parnell’s US Pet Care business. Her responsibilities will include commercial strategy, customer engagement, organisational development and growth initiatives aimed at expanding access to solutions for veterinary professionals and the animals they treat.
Parnell said Holt received the OnePet Innovation Award and Global Excellence Award from Boehringer Ingelheim in 2025, followed by its President’s Club Award in 2026.
“Sharon is a highly respected leader with a proven track record of delivering results, building high-performing teams and creating meaningful value for customers,” said Pablo Lamberto, DVM, US General Manager at Parnell. “Her deep understanding of the companion animal market, combined with her passion for customer success and innovation, makes her an outstanding addition to the Parnell leadership team.”
The company has expanded its US Pet Care portfolio with products covering anesthesia and beyond. The company also offers the Foundations of Anesthesia & Sedation Veterinary Certificate, an online programme providing 10 RACE-approved continuing education hours.
